Hip Replacement in Ankylosing Spondylitis Patients with Advanced Hip Involvement: Factors Associated with Bilateral Total Hip Arthroplasty

References

• Marks JS, Hardinge K. Clinical and radiographic features of spondylitic hip disease. Ann Rheum Dis. 1979;38(4):332–336. doi:10.1136/ard.38.4.332
   PubMed Web of Science ®Google Scholar
• Dwosh IL, Resnick D, Becker MA. Hip involvement in ankylosing spondylitis. Arthritis Rheum. 1976;19(4):683–692. doi:10.1002/1529-0131(197607/08)19:4<683::aid-art1780190405>3.0.co;2-8
   PubMed Web of Science ®Google Scholar
• Vander Cruyssen B, Vastesaeger N, Collantes-Estévez E. Hip disease in ankylosing spondylitis. Curr Opin Rheumatol. 2013;25(4):448–454. doi:10.1097/BOR.0b013e3283620e04
   PubMed Web of Science ®Google Scholar
• Vander Cruyssen B, Muñoz-Gomariz E, Font P, et al. Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery. Rheumatology. 2010;49(1):73–81. doi:10.1093/rheumatology/kep174
   PubMed Web of Science ®Google Scholar
• Braun J, van den Berg R, Baraliakos X, et al. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis. 2011;70(6):896–904. doi:10.1136/ard.2011.151027
   PubMed Web of Science ®Google Scholar
• Lin D, Charalambous A, Hanna SA. Bilateral total hip arthroplasty in ankylosing spondylitis: a systematic review. EFORT Open Rev. 2019;4(7):476–481. doi:10.1302/2058-5241.4.180047
   PubMed Web of Science ®Google Scholar
• van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27(4):361–368. doi:10.1002/art.1780270401
   PubMed Web of Science ®Google Scholar
• MacKay K, Brophy S, Mack C, Doran M, Calin A. The development and validation of a radiographic grading system for the hip in ankylosing spondylitis: the bath ankylosing spondylitis radiology hip index. J Rheumatol. 2000;27(12):2866–2872.
   PubMed Web of Science ®Google Scholar
• Sochart DH, Porter ML. Long-term results of total hip replacement in young patients who had ankylosing spondylitis. Eighteen to thirty-year results with survivorship analysis. J Bone Joint Surg Am. 1997;79(8):1181–1189. doi:10.2106/00004623-199708000-00010
   PubMed Web of Science ®Google Scholar
• Brinker MR, Rosenberg AG, Kull L, Cox DD. Primary noncemented total hip arthroplasty in patients with ankylosing spondylitis. Clinical and radiographic results at an average follow-up period of 6 years. J Arthroplasty. 1996;11(7):802–812. doi:10.1016/s0883-5403(96)80180-x
   PubMed Web of Science ®Google Scholar
• Bhan S, Pankaj A, Malhotra R. One- or two-stage bilateral total hip arthroplasty: a prospective, randomised, controlled study in an Asian population. J Bone Joint Surg Br. 2006;88(3):298–303. doi:10.1302/0301-620X.88B3.17048
   PubMedGoogle Scholar
• Bangjian H, Peijian T, Ju L. Bilateral synchronous total hip arthroplasty for ankylosed hips. Int Orthop. 2012;36(4):697–701. doi:10.1007/s00264-011-1313-8
   PubMed Web of Science ®Google Scholar
• Bukowski BR, Clark NJ, Taunton MJ, Freedman BA, Berry DJ, Abdel MP. Revision Total Hip Arthroplasty in Patients With Ankylosing Spondylitis: long-Term Results. J Arthroplasty. 2020;35(9):2573–2580. doi:10.1016/j.arth.2020.04.071
   PubMed Web of Science ®Google Scholar
• Joshi AB, Markovic L, Hardinge K, Murphy JCM. Total hip arthroplasty in ankylosing spondylitis: an analysis of 181 hips. J Arthroplasty. 2002;17(4):427–433. doi:10.1054/arth.2002.32170
   PubMed Web of Science ®Google Scholar
• Zhao J, Zheng W, Zhang C, Li J, Liu D, Xu W. Radiographic Hip Involvement in Ankylosing Spondylitis: factors Associated with Severe Hip Diseases. J Rheumatol. 2015;42(1):106–110. doi:10.3899/jrheum.140428
   PubMed Web of Science ®Google Scholar
• Wink F, Arends S, Maas F, et al. High prevalence of hip involvement and decrease in inflammatory ultrasound lesions during tumour necrosis factor-α blocking therapy in ankylosing spondylitis. Rheumatology. 2019;58(6):1040–1046. doi:10.1093/rheumatology/key382
   PubMed Web of Science ®Google Scholar
• Calin A, Elswood J. The relationship between pelvic, spinal and hip involvement in ankylosing spondylitis–one disease process or several? Br J Rheumatol. 1988;27(5):393–395. doi:10.1093/rheumatology/27.5.393
   PubMedGoogle Scholar
• Chen D, Yuan S, Zhan Z, et al. Early-stage hip involvement in patients with ankylosing spondylitis: a Chinese study based on magnetic resonance imaging. Mod Rheumatol. 2016;26(6):933–939. doi:10.3109/14397595.2016.1153232
   PubMed Web of Science ®Google Scholar
• de Vries MK, van Eijk IC, van der Horst-bruinsma IE, et al. Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis. Arthritis Rheum. 2009;61(11):1484–1490. doi:10.1002/art.24838
   PubMed Web of Science ®Google Scholar
• Maxwell LJ, Zochling J, Boonen A, et al. TNF-alpha inhibitors for ankylosing spondylitis. Cochrane Database Syst Rev. 2015;1(4):CD005468. doi:10.1002/14651858.CD005468.pub2
   Web of Science ®Google Scholar
• Callhoff J, Sieper J, Weiß A, Zink A, Listing J. Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis. Ann Rheum Dis. 2015;74(6):1241–1248. doi:10.1136/annrheumdis-2014-205322
   PubMed Web of Science ®Google Scholar
• Vander Cruyssen B, Ribbens C, Boonen A, et al. The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice. Ann Rheum Dis. 2007;66(8):1072–1077. doi:10.1136/ard.2006.064543
   PubMed Web of Science ®Google Scholar
• Lian F, Yang X, Liang L, et al. Treatment efficacy of etanercept and MTX combination therapy for ankylosing spondylitis hip joint lesion in Chinese population. Rheumatol Int. 2012;32(6):1663–1667. doi:10.1007/s00296-011-1844-8
   PubMed Web of Science ®Google Scholar
• Wang D, Ma L, Wu D. Efficacy of etanercept in ankylosing spondylitis hip lesions. Joint Bone Spine. 2011;78(5):531–532. doi:10.1016/j.jbspin.2011.03.023
   PubMed Web of Science ®Google Scholar
• Konsta M, Sfikakis PP, Bournia VK, Karras D, Iliopoulos A. Absence of radiographic progression of hip arthritis during infliximab treatment for ankylosing spondylitis. Clin Rheumatol. 2013;32(8):1229–1232. doi:10.1007/s10067-013-2263-x
   PubMed Web of Science ®Google Scholar
• Song R, Chung SW, Lee S-H. Radiographic Evidence of Hip Joint Recovery in Patients with Ankylosing Spondylitis after Treatment with Anti-tumor Necrosis Factor Agents: a Case Series. J Rheumatol. 2017;44(11):1759–1760. doi:10.3899/jrheum.161401
   PubMed Web of Science ®Google Scholar
• Rocha FAC, Pinto ACMD, Lopes JR, Deodhar A. Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis-time to reconsider treatment guidelines? A case series and review of literature. Clin Rheumatol. 2020. doi:10.1007/s10067-020-05519-0
   PubMed Web of Science ®Google Scholar
• Nystad TW, Furnes O, Havelin LI, Skredderstuen AK, Lie SA, Fevang B-TS. Hip replacement surgery in patients with ankylosing spondylitis. Ann Rheum Dis. 2014;73(6):1194–1197. doi:10.1136/annrheumdis-2013-203963
   PubMed Web of Science ®Google Scholar